FimmCyte Companies
FimmCyte develops a novel immune system-based treatment, which demonstrated positive results through early preclinical studies.
Industry:
Pelvic & Uterine Healthcare
Headquarters:
Basel, Basel-Stadt, Switzerland
Founded Date:
2022
Employees Number:
10-Jan
Register and Claim Ownership